International Stem Cell CORP (ISCO) › Cash & EquivalentsInternational Stem Cell CORP (ISCO) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2009: $727.0K2010: $5.78M2011: $1.34M2012: $654.0K2013: $2.24M2014: $1.11M2015: $532.0K2016: $110.0K2017: $304.0K$304.0K2009Cash & Equivalents (USD)2017Fiscal YearCash & EquivalentsChange YoY2017$304.0K+176.4%2016$110.0K-79.3%2015$532.0K-52.1%2014$1.11M-50.5%2013$2.24M+243.0%2012$654.0K-51.1%2011$1.34M-76.9%2010$5.78M+695.3%2009$727.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share